Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Pharmacological Treatment of the Frail Patient: Integrated CARE and Real-Time Monitoring at Home (FRAIL-CARE).

NCT07903584 is registered in ClinicalTrials.gov with Istituti Clinici Scientifici Maugeri SpA as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07903584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Pharmacological Treatment of the Frail Patient: Integrated CARE and Real-Time Monitoring at Home (FRAIL-CARE).
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
Phase
Not applicable
Overall status
Completed
Start date
September 24, 2025
Completion date
June 30, 2026
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

frailty, multimorbidity, polypharmacy (people under treatment with 5 or more drugs)

Arms

As registered; 1 arm.

  • FRAIL-CARE integrated home care ExperimentalBlood drug concentration monitoring beyond routine TDM, Healthcare device, Remote monitoring by Specialist Operations Centres

    Frail patients older than 65 years with polypharmacy discharged home. For 6 months they use the RiAtlas Healthcare app and Checkme Pro device, are followed remotely by Specialist Operations Centres (weekly calls, alerts, 24/7 urgent support), and have blood levels of prescribed drugs measured at discharge, 3 and 6 months and when clinically needed.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in health-related quality of life (EQ-5D-5L) Baseline (T0), 3 months (T1) and 6 months (T2)

    Health-related quality of life assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. The questionnaire evaluates five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.For each dimension, patients select one of five response options, ranging from no problems to extreme problems or inability to perform the activity. Higher levels of reported problems indicate worse health status. The questionnaire also includes a self-rated health scale ranging from 0 (worst imaginable health state) to 100 (best imaginable health state), with higher scores indicating better perceived health. Assessments are performed at enrolment (T0), 3 months (T1), and 6 months (T2)

Lead sponsor's other trials

Istituti Clinici Scientifici Maugeri SpA, most recent start first.

Similar trials

Same condition (Frailty) and phase, most recent start first.